Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Signaling through CD80: an approach for treating lymphomas.

Manzoor A Mir1, Javed N Agrewala

  • 1Institute of Microbial Technology, Sector 39A, Chandigarh-160036, India.

Expert Opinion on Therapeutic Targets
|July 16, 2008
PubMed
Summary

Targeting CD80 (cluster of differentiation 80) with immunotherapy shows promise for treating cancers. This approach may help generate effective immune responses against CD80-expressing tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infection.

Journal of virology·2026
Same author

Morphine disrupts antigen-presenting cell function through TLR-4 and autophagy pathways.

Molecular biology reports·2026
Same author

Editorial: p53 in cancer therapy: the impact of mutations on the genome guardian.

Frontiers in immunology·2026
Same author

Cytochrome c as a central regulator of mitochondrial function in cancer metabolism.

Discover oncology·2026
Same author

Two-Step Strategy to Design Organo-Fluorophore: Engaging Palladium Catalysis for Carbo-Oxygenative Cyclization of Chloroprene Derivatives.

Organic letters·2026
Same author

Mycobacterial and monkeypox homologous epitopes: Building blocks of a robust monkeypox vaccine.

Journal of biosciences·2025

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumors evade immune detection by reducing costimulatory molecules like CD80 and CD86.
  • CD80 plays a crucial role in T-cell activation, with ongoing research into its cancer implications.

Purpose of the Study:

  • To investigate the potential role of CD80 signaling in eliciting an effective anti-cancer immune response.

Main Methods:

  • Reviewed literature on CD80's impact on B-cell and follicular lymphoma growth.
  • Examined CD80 signaling's effects on apoptosis-related molecules in lymphomas.
  • Considered findings from a Phase I/II study of CD80-specific antibody treatment.

Main Results:

  • CD80 signaling can inhibit lymphoma proliferation by modulating apoptotic pathways.
  • A CD80-specific antibody demonstrated significant efficacy in relapsed/refractory follicular lymphoma patients.

Conclusions:

  • Anti-CD80 immunotherapy presents a potential therapeutic strategy for cancers expressing CD80.

More Related Videos

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Related Experiment Videos

Last Updated: Jul 3, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018